Combined Allergic Rhinitis and Asthma Syndrome
Conditions
Interventions
Control Group:Oral Montelukast Sodium Chewable Tablets
Treatment Group:Oral Montelukast Sodium Chewable Tablets and Tuina treatment
Sponsors
Shanghai Municipal Hospital of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
6 Years to 14 Years
Inclusion criteria
Inclusion criteria: a) Meeting the Western medicine diagnostic criteria and traditional Chinese medicine diagnostic criteria specified in the "Expert Consensus on Integrated Traditional Chinese and Western Medicine Diagnosis and Treatment of Allergic Rhinitis-Asthma Syndrome"; b) The disease is in the remission stage; c) Aged 6-14 years; d) The guardian of the child has signed the informed consent form. e) Children aged =8 years have signed the informed consent form.
Exclusion criteria
Exclusion criteria: a) Patients with nasal congestion and runny nose caused by acute rhinitis, vasomotor rhinitis, etc.; b) Children with congenital nasal physiological abnormalities (such as nasal stenosis, deviated nasal septum, adenoid hypertrophy, etc.); c) Patients with wheezing discomfort caused by bacterial bronchitis, bronchial developmental malformations or airway foreign bodies, respiratory failure, bronchiectasis, chronic obstructive pulmonary disease, etc.; d) Children with primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system diseases; e) Children participating in other research groups; f) Those who cannot cooperate with the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pediatric Rhinoconjunctivitis Quality of Life Questionnaire Score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Childhood Asthma Control Test Score;Asthma Control Test Score;TCM Symptom Score; | — |
Countries
China
Contacts
Public ContactJunhao Cai
Shanghai Municipal Hospital of Traditional Chinese Medicine
Outcome results
None listed